Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human MYB Antibodies:
anti-Mouse (Murine) MYB Antibodies:
anti-Rat (Rattus) MYB Antibodies:
Go to our pre-filtered search.
Human Monoclonal MYB Primary Antibody for WB - ABIN1944794
Majello, Kenyon, Dalla-Favera: Human c-myb protooncogene: nucleotide sequence of cDNA and organization of the genomic locus. in Proceedings of the National Academy of Sciences of the United States of America 1987
Show all 3 Pubmed References
Human Polyclonal MYB Primary Antibody for ELISA, ICC - ABIN6263448
Huang, Zhang, Hou, Wang, Liu, Zhang, Chen, Zhu: LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. in Journal of experimental & clinical cancer research : CR 2018
Human Polyclonal MYB Primary Antibody for IHC (p), IHC - ABIN253301
Clappier, Cuccuini, Kalota, Crinquette, Cayuela, Dik, Langerak, Montpellier, Nadel, Walrafen, Delattre, Aurias, Leblanc, Dombret, Gewirtz, Baruchel, Sigaux, Soulier: The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. in Blood 2007
Cow (Bovine) Polyclonal MYB Primary Antibody for ELISA, WB - ABIN4285666
Fahl, Crittenden, Allman, Bender: c-Myb is required for pro-B cell differentiation. in Journal of immunology (Baltimore, Md. : 1950) 2009
These results indicated that low expression of Mda-7/IL-24 (show IL24 Antibodies) along with high expression of C-myb are predictors for poor prognosis of Burkitt lymphoma patients; this outcome suggests that Mda-7/IL-24 (show IL24 Antibodies) and C-myb might be potential targets for clinical treatment of Burkitt lymphoma.
C-Myb expression in the laryngeal squamous cell carcinoma.YB-1 regulates miR (show MLXIP Antibodies)-155 expression via c-Myb in the laryngeal squamous cell carcinoma.
Data indicate a pioneer factor model in which c-Myb binds to regions of closed chromatin and then recruits histone acetyltransferases. By binding to histones, c-Myb facilitates histone acetylation, acting as a cofactor for p300 (show EP300 Antibodies) at c-Myb binding sites. The resulting H3K27ac leads to chromatin opening and detachment of c-Myb from the acetylated chromatin.
Both cases harbored the MYB-NFIB (show NFIB Antibodies) gene fusion as demonstrated by FISH and RNA-sequencing
Expression of c-Myb, a regulatory factor of B lymphocytes, is increased in B lymphocytes of AIHA/Evans patients, while miR (show MLXIP Antibodies)-150 expression is decreased. c-Myb was negatively correlated with miR (show MLXIP Antibodies)-150.
genome-wide association analyses identified a new genome-wide significant locus on the HBS1L (show HBS1L Antibodies)-MYB intergenic region for platelet-to-lymphocyte ratio
identified a high frequency of MYB rearrangements that promoted the MYB transcriptional activity in BPDCN. MYB split FISH analysis can constitute a valuable diagnostic tool for detecting MYB rearrangements
Studied association of BCL11A single nucleotide polymorphisms(snps) and HBS1L-MYB Intergenic snps with Hereditary Persistence of Fetal Hemoglobin (HPFH) in a cohort of sickle cell patients.
NFIB (show NFIB Antibodies)-associated gene rearrangement is a frequent genetic event in vulvar adenoid cystic carcinomas. Chromosome translocations involving NFIB (show NFIB Antibodies) but with an intact MYB indicate the presence of novel oncogenic mechanisms for the development of adenoid cystic carcinomas of the vulva.
Expression of the MYB-NFIB (show NFIB Antibodies) fusion oncogene (show RAB1A Antibodies) in mammary tissue resulted in hyperplastic glands that developed into adenocarcinoma.
This study provides evidence that c-Myb might serve as a new target for the prevention of aminoglycoside-induced hair cells loss.
these results identify a key role for miR (show MLXIP Antibodies)-150 in memory CD8 (show CD8A Antibodies) T cells through a c-Myb-controlled enhanced survival circuit.
Myb knockdown in Setbp1 (show SETBP1 Antibodies) and Setbp1 (show SETBP1 Antibodies) missense mutations-induced AML (show RUNX1 Antibodies) cells also efficiently induced their differentiation in culture and significantly prolonged the survival of their secondary recipient mice.
These findings reveal miR (show MLXIP Antibodies)-301b as a new controller of inflammatory response by repressing c-Myb function to inhibit the anti-inflammatory response to bacterial infection, representing a novel mechanism for balancing inflammation.
The analysis points to a critical role for Hoxa9 (show HOXA9 Antibodies) and PU.1 in distal regulation of c-myb expression in murine myeloid cells during iL-6 (show IL6 Antibodies)-induced cell differentiation.
Data suggest that the upregulations of Myb and Peg3 (show PEG3 Antibodies) are likely the key anti-cancer events of EGCG in vivo.
deficiency alters the expression of a crucial subset of TAL1 (show TAL1 Antibodies)- and NOTCH1 (show NOTCH1 Antibodies)-regulated genes, including the MYB and MYC (show MYC Antibodies) oncogenes, respectively.
MYB acts on MAPK (show MAPK1 Antibodies) signaling by directly regulating transcription of the gene encoding the negative modulator SPRY2 (show SPRY2 Antibodies).
This work provides important mechanistic insight into how spatiotemporal expression of the Rag genes is tightly controlled during B lymphocyte (show AKAP17A Antibodies) development to prevent mistimed dsDNA breaks and their deleterious consequences.
These results Myb as a critical component of the gene regulatory network controlling effector Treg cell differentiation and function.
studies show that merestinib effectively blocks eIF4E phosphorylation in AML (show RUNX1 Antibodies) cells and suppresses primitive leukemic progenitors from AML (show RUNX1 Antibodies) patients in vitro and in an AML (show RUNX1 Antibodies) xenograft model in vivo.
cMyb plays a hitherto unidentified role in dictating physiologic HSPC (show PSMA7 Antibodies) migration by modulating Sdf1a (show CXCL12 Antibodies) signaling.
show that knockdown of miR (show MYLIP Antibodies)-126 results in increased c-Myb levels and promotes erythropoiesis at the expense of thrombopoiesis in vivo
Results suggest that the key role of c-myb in definitive hematopoiesis is similar to that in mammals and must have become established early in vertebrate evolution.
expression of CD41 and cmyb marks nascent HSCs in the zebrafish AGM (show IGFBP7 Antibodies), and provide the means to further dissect HSC (show FUT1 Antibodies) generation and
This gene encodes a transcription factor that is a member of the MYB family of transcription factor genes. The protein contains three domains, an N-terminal DNA-binding domain, a central transcriptional activation domain and a C-terminal domain involved in transcriptional repression. This protein plays an essential role in the regulation of hematopoiesis and may play a role in tumorigenesis. Alternative splicing results in multiple transcript variants.
c-myb protein (140 AA)
, proto-oncogene c-Myb
, transcriptional activator Myb
, gag-myb protein
, myb proto-oncogene protein
, myeloblastosis proto-oncogene product
, tumor-specific myb protein
, myeloblastosis oncogene
, Avian myeloblastosis viral (v-myb) oncogene homolog
, v-myb myeloblastosis viral oncogene homolog (avian)
, transcriptional activator Myb-like
, DNA-binding transcriptional regulator
, c-myb proto-oncogene
, transcription factor cmyb
, v-myb myeloblastosis viral oncogene homolog
, v-myb avian myeloblastosis viral oncogene homolog